Abstract | AIMS: METHODS: MDCs were isolated from an upper-arm muscle biopsy from 16 women with SUI. Cells were isolated by enzymatic digestion and expanded in vitro for 8-10 weeks. A quantity of 0.6-25 × 10(6) of the obtained cells were injected transurethrally into the urethral rhabdosphincter of women under local anesthesia. The cells were placed circumferentially at the 9, 12, and 3 O'clock positions with endoscopic guidance. RESULTS: The initial results of the treatment of SUI with adult muscle-derived stem cells demonstrate the safety and feasibility of using these cells. The 2-year follow-up revealed a 75% success rate, with some patients achieving complete improvement (50%) and some patients achieving partial improvement (25%), suggesting that the prospects for this method are encouraging. CONCLUSIONS: Stem cell therapy promises to become a minimally invasive method for the regeneration of the urethral rhabdosphincter muscle. Injecting a small number of cells does not preclude obtaining the desired therapeutic result.
|
Authors | Klaudia Stangel-Wojcikiewicz, Danuta Jarocha, Monika Piwowar, Robert Jach, Tadeusz Uhl, Antoni Basta, Marcin Majka |
Journal | Neurourology and urodynamics
(Neurourol Urodyn)
Vol. 33
Issue 3
Pg. 324-30
(Mar 2014)
ISSN: 1520-6777 [Electronic] United States |
PMID | 23606303
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | © 2013 Wiley Periodicals, Inc. |
Topics |
- Autografts
- Cells, Cultured
- Endoscopy
- Feasibility Studies
- Female
- Humans
- Middle Aged
- Muscle, Skeletal
(cytology, transplantation)
- Poland
- Recovery of Function
- Regeneration
- Stem Cell Transplantation
(adverse effects, methods)
- Time Factors
- Treatment Outcome
- Upper Extremity
- Urethra
(physiopathology)
- Urinary Bladder
(physiopathology)
- Urinary Incontinence, Stress
(diagnosis, physiopathology, therapy)
- Urodynamics
|